leadf
logo-loader
viewBioLargo, Inc.

BioLargo's CupriDyne-based disinfectant kills the coronavirus in 10 minutes, study says

The results were achieved in a third-party study of a modified CupriDyne formula at the Galveston National Laboratory at the University of Texas Medical Branch

Coronavirus graphic
BioLargo plans to file for EPA registration for the new faster-acting CupriDyne formula which has yet to be named

BioLargo Inc (OTCQB:BLGO) told investors Wednesday that its patented CupriDyne disinfectant was able to completely inactivate the SARS-CoV-2, the virus that causes COVID-19, in just 10 minutes. 

The results were achieved in a third-party study of a modified CupriDyne formula at the Galveston National Laboratory at the University of Texas Medical Branch, the company said.

BioLargo had previously announced that CupriDyne was capable of reducing SARS-CoV-2 titers by 99% after 30 minutes, with complete inactivation after an hour.

READ: BioLargo unveils first municipal wastewater trial of water treatment technology

BioLargo plans to file for EPA registration for the new faster-acting formula ,which has yet to be named.

“We believe that the future is bright for our CupriDyne-based disinfectants,” CEO Dennis Calvert said. “We intend to apply for registration with the EPA once product designs are finalized.”

Achieving inactivation after 10 minutes is comparable to what you see with highly concentrated bleach.

“It is important to understand that we are achieving these extraordinary results at a significantly lower concentration than that of bleach in the same test protocol,” Calvert said.

“We have retained a leading EPA consulting firm to lead us in the EPA registration process and intend to move ahead as soon as possible. These products are a great addition to our expanding portfolio."

BioLargo is an innovator of technology-based products and environmental engineering solutions including what the company says are “unique disruptive solutions” to deliver cleaner air, water and a “clean, safe environment”.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: BioLargo, Inc.

Price: 0.139 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $29.69 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo awarded contract at major chemical manufacturing plant for...

BioLargo (OTCQB: BLGO) CEO Dennis Calvert joined Steve Darling from Proactive Vancouver with news the company’s subsidiary BioLargo Engineering, Science & Technologies has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer systems used at a large...

4 days, 5 hours ago

2 min read